TWD
CABA icon

True Wealth Design’s Cabaletta Bio CABA Stock Holding History

True Wealth Design’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17
Closed -$26 – 2739
2025
Q2 		$26 Sell
17
-46
-73% -$72 ﹤0.01% 2484
2025
Q1 		$88 Buy
+63
New +$134 ﹤0.01% 2234

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

True Wealth Design's CABA Position: Q3 2025 in Review

True Wealth Design sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 17 shares — an estimated $26 sold.

True Wealth Design first reported a position in CABA in Q1 2025 and held it in 2 quarters. The position peaked at $88 in Q1 2025. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • True Wealth Design reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • True Wealth Design sold 17 Cabaletta Bio shares in Q3 2025, an estimated $26.
  • True Wealth Design first reported a position in Cabaletta Bio in Q1 2025 and held it in 2 quarters.
  • True Wealth Design's Cabaletta Bio position peaked at $88 in Q1 2025.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.